Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05568199 · ClinicalTrials.gov registry record
Udall Project 1 Aim 4
A clinical trial of Parkinson's Disease and Deep Brain Stimulation, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05568199: Recruiting study of Parkinson's Disease and Deep Brain Stimulation, sponsored by University of Minnesota.
NCT05568199 is a study of Parkinson's Disease and Deep Brain Stimulation that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05568199, a study of Parkinson's Disease and Deep Brain Stimulation, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
By defining the strength and direction of connectivity patterns at rest and during movement across the basal ganglia-thalamocortical (BGTC) network we will characterize the role of individual circuits in motor performance and cognitive function, paving the way for future development of optimization algorithms for DBS that take advantage of this understanding.
Primary Outcome
associate pathway activation patterns with motor (UPDRS-III) outcome obtained during standard of care and research appointments.
Conditions Studied
Study Locations (1)
Minnesota
- University Of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-05 |
| Est. Completion | 2035-01-01 |
What NCT05568199 shows while recruiting
NCT05568199 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05568199 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05568199 about?
NCT05568199 is a clinical study titled "Udall Project 1 Aim 4". By defining the strength and direction of connectivity patterns at rest and during movement across the basal ganglia-thalamocortical (BGTC) network we will characterize the role of individual circuits in motor performance and cognitive function, paving the way for future development of optimization ...
What is the current status of trial NCT05568199?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-03-05. Estimated completion is 2035-01-01.
What conditions does trial NCT05568199 study?
This clinical trial studies the following conditions: Parkinson's Disease, Deep Brain Stimulation.
Who is sponsoring clinical trial NCT05568199?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05568199 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05568199's enrollment target sits among peer trials
100 55th of 158 higher than 100 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI